NO975238L - Muskeltrofisk faktor - Google Patents

Muskeltrofisk faktor

Info

Publication number
NO975238L
NO975238L NO975238A NO975238A NO975238L NO 975238 L NO975238 L NO 975238L NO 975238 A NO975238 A NO 975238A NO 975238 A NO975238 A NO 975238A NO 975238 L NO975238 L NO 975238L
Authority
NO
Norway
Prior art keywords
muscular
methods
preparations
trophic factor
farm
Prior art date
Application number
NO975238A
Other languages
English (en)
Other versions
NO975238D0 (no
Inventor
Kenneth H Grabstein
Lebris S Ouinn
Anthony B Troutt
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of NO975238D0 publication Critical patent/NO975238D0/no
Publication of NO975238L publication Critical patent/NO975238L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparater og fremgangsmåter for stimulering av muskelvekst eller differensiering hos en vertebrat. Slike preparater omfatter en muskeltrofisk mengde av interleukin-15 og kan anvendes for å behandle ulike tilstander, deriblant inaktivitets- atrofi, svinn av vev, ulike aldersrelaterte forstyrrelser, bivirkninger av diabetes, deriblant glukoseintoleranse, i tillegg til muskulaer dystrofi, rhabdomyosarkom og kongestiv hjertesvikt. Preparatene og fremgangsmåtene ifølge oppfinnelsen kan brukes innen landbruket for økning av effektiviteten ved kjøtt- og melkeproduksjon fra gårdsdyr.
NO975238A 1995-05-24 1997-11-14 Muskeltrofisk faktor NO975238L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/535,733 US5660824A (en) 1995-05-24 1995-05-24 Muscle trophic factor
PCT/US1996/006423 WO1996037223A1 (en) 1995-05-24 1996-05-07 Muscle trophic factor

Publications (2)

Publication Number Publication Date
NO975238D0 NO975238D0 (no) 1997-11-14
NO975238L true NO975238L (no) 1998-01-23

Family

ID=24135542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975238A NO975238L (no) 1995-05-24 1997-11-14 Muskeltrofisk faktor

Country Status (9)

Country Link
US (1) US5660824A (no)
EP (1) EP0831902A4 (no)
JP (1) JPH11505836A (no)
KR (1) KR19990014835A (no)
AU (1) AU705609B2 (no)
CA (1) CA2221148C (no)
NO (1) NO975238L (no)
NZ (1) NZ307845A (no)
WO (1) WO1996037223A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1200037A (zh) 1995-10-17 1998-11-25 韦恩州立大学 鸡白细胞介素－15及其用途
US6511848B2 (en) * 1996-04-17 2003-01-28 Winfried Albert Process for producing and multiplying lymphocytes
US6087172A (en) * 1997-10-31 2000-07-11 Hisamitsu Pharmaceutical Co., Inc. Ribozymes targeted to human IL-15 mRNA
US6828147B1 (en) 1999-02-24 2004-12-07 The Wistar Institute Of Anatomy And Biology Method of modifying cytotoxic cells and uses thereof
US6750194B1 (en) 2000-10-23 2004-06-15 The Procter & Gamble Company Methods of identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
US6670140B2 (en) 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
RS51829B (sr) * 2001-08-23 2012-02-29 Genmab A/S. Ljudska antitela specifična za interleukin 15 (il-15)
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
US6936585B2 (en) 2002-01-16 2005-08-30 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
EP3263581B2 (en) 2005-05-17 2025-07-09 University of Connecticut Compositions and methods for immunomodulation in an organism
NZ569541A (en) 2006-01-13 2012-05-25 Us Gov Health & Human Serv Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
NZ599338A (en) 2007-06-27 2013-11-29 Marinepolymer Tech Inc Complexes of il-15 and il-15ralpha and uses thereof
WO2009135031A1 (en) 2008-04-30 2009-11-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic Substituted il-15
ES2598005T3 (es) 2009-08-14 2017-01-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Uso de IL-15 para aumentar la salida del timo y para tratar la linfopenia
CN108474007A (zh) 2015-08-07 2018-08-31 联邦科学技术研究组织 产生包含种系遗传修饰的动物的方法
CA3065317A1 (en) 2017-05-31 2018-12-06 Commonwealth Scientific And Industrial Research Organisation Trait selection in avians

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448879A (en) * 1981-03-26 1984-05-15 Hooper Trading Company High yield process for in vitro production of serum-free and mitogen-free interleukin-2

Also Published As

Publication number Publication date
AU705609B2 (en) 1999-05-27
NO975238D0 (no) 1997-11-14
AU5730796A (en) 1996-12-11
CA2221148A1 (en) 1996-11-28
NZ307845A (en) 1999-10-28
EP0831902A1 (en) 1998-04-01
CA2221148C (en) 2000-10-24
KR19990014835A (ko) 1999-02-25
MX9708853A (es) 1998-03-31
WO1996037223A1 (en) 1996-11-28
EP0831902A4 (en) 2002-04-17
JPH11505836A (ja) 1999-05-25
US5660824A (en) 1997-08-26

Similar Documents

Publication Publication Date Title
NO975238L (no) Muskeltrofisk faktor
WO2003022208A3 (en) Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
DE10209822A1 (de) Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
GB2344519B (en) Sterile therapeutic compositions
DE3729953C2 (de) Mittel zur Förderung und Stimulierung des Haarwachstums und zur Verringerung von Haarausfall auf Basis von Nikotinsäureestern und Pyrimidinderivaten
DE2006446C3 (de) Verfahren zur Herstellung von Bleomycin-Antibiotika sowie Bleomycine mit strukturell abgewandelter Seitenkette
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69623644D1 (de) Verwendung einer desaminierenden oxidase zum backen
WO1996015758A3 (en) Methods for stimulating erythropoiesis using thrombopoietin
DE69105077D1 (de) Verwendung von Polysacchariden in Zubereitungen zur Wundbehandlung.
CA2283676A1 (en) Stimulation, culture and preservation of pancreatic and other cells
DE69902397D1 (de) Neues verfahren zur kryokonservierung von pflanzen
RU99105184A (ru) Способ возделывания хлопчатника
MD2133G2 (ro) Procedeu de stimulare a creşterii tutunului
WO2005062942A3 (en) Novel oligonucleotides and treating cardiac disorders by using the same
DE69820911D1 (de) Verwendung einer Verbindung zur Herstellung eines Medikaments zur Behandlung von Alopecia oder zur Förderung des Haarwuchses bei Tieren
DE69124382D1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
UA23999A (uk) Спосіб одержаhhя засобу "біпекс" для лікуваhhя hейрооhкологічhих захворюваhь
IS5805A (is) Efni, samsetning og aðferðir til þess að örva taugavöxt og lengingu á taugaendum
MD650G2 (ro) Procedeu de stimulare a creşterii răsadului de tutun
RU2001107421A (ru) Способ получения биологического удобрения
JPS596621B2 (ja) 漬物用醤油液及び該醤油液の製造法

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application